3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
376
Neoplasm Metastasis
21
Neoplasms
11
Advanced Breast Cancer
10
Carcinoma, Intraductal, Noninfiltrating
8
Triple Negative Breast Neoplasms
7
Osteoporosis
7
Carcinoma, Ductal, Breast
7
Breast Neoplasms, Male
7
Breast Diseases
7
Breast Carcinoma In Situ
6
Carcinoma, Lobular
5
Prostatic Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Breast Cancer Metastatic
4
Arthralgia
4
Recurrence
3
Ovarian Neoplasms
3
Neoplasms, Hormone-Dependent
3
Squamous Cell Carcinoma of Head and Neck
2
Pain
2
Obesity
2
Neoplasms by Site
2
Multiple Endocrine Neoplasia Type 1
2
Infertility
2
Head and Neck Neoplasms
2
HR+/HER2- Breast Cancer
2
HR Positive HER2 Negative Advanced Breast Cancer
2
Estrogen Receptor-positive Breast Cancer
2
Endometrial Neoplasms
2
Interventions
Surveys and Questionnaires
3
Blood Specimen Collection
3
veliparib
2
Salpingo-oophorectomy
2
Genetic Testing
2
Genetic Counseling
2
Diet, Mediterranean
2
Counseling
2
Carboplatin
2
prexasertib
1
Zoledronic Acid
1
Videotape Recording
1
Telemedicine
1
Taxes
1
Tamoxifen
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Salpingectomy
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Palliative Care
1
Paclitaxel
1
Ovariectomy
1
Methods
1
Letrozole
1
Hysterectomy
1
High-Throughput Nucleotide Sequencing
1
Genotype
1
Exercise Test
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hereditary Breast and Ovarian Cancer Syndrome
×
Letrozole
×
Breast
×
Clear all
NCT00673335
2024-07-01
LIBER
UNICANCER
Phase 3
Completed
170 enrolled